In a Phase III randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better ...
Stereotactic radiation improved key quality-of-life outcomes among patients with multiple brain metastases compared with hippocampal-avoidance whole-brain radiation (HA-WBRT), a phase III randomized ...
Mass General Brigham researchers are betting that the next big leap in brain medicine will come from teaching artificial ...
BrainIAC is an innovative AI foundation model developed by Mass General Brigham that was trained on nearly 49,000 brain MRI scans to identify key neurological health indicators, such as brain age and ...
In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom ...
Brain radiotherapy combined with ICIs improved overall survival and intracranial local control in SCLC patients with brain metastases. WBRT with simultaneous integrated boost (SIB) showed better ...
BrainIAC is a foundation AI model for brain MRIs that spots dementia risk, tumors, and aging better than old tech by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results